Live Status Check

NCT05932680 Recruiting Status

Real-time enrollment status for this i cannot determine a primary medical condition from this data. the study title mentions "teclistamab" (a drug) and the listed condition is "other:off drug surveillance" which refers to monitoring rather than a medical condition. there are no keywords or meaningful brief summary provided to identify what health issue this study addresses. clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 8:48 AM UTC

NCT05932680 Status Summary

NCT NumberNCT05932680
Recruiting StatusRecruiting
ConditionI cannot determine a primary medical condition from this data. The study title mentions "Teclistamab" (a drug) and the listed condition is "OTHER:Off Drug Surveillance" which refers to monitoring rather than a medical condition. There are no keywords or meaningful brief summary provided to identify what health issue this study addresses.
PhaseClinical Trial
Target Enrollment75 participants
Active Locations4 sites in the US
SponsorAbramson Cancer Center at Penn Medicine
Last Updated on CT.govOctober 1, 2025 (Oct 1, 2025)

About NCT05932680 Enrollment Status

As of March 2, 2026: Clinical trial NCT05932680 is currently recruiting participants. This clinical trial study for i cannot determine a primary medical condition from this data. the study title mentions "teclistamab" (a drug) and the listed condition is "other:off drug surveillance" which refers to monitoring rather than a medical condition. there are no keywords or meaningful brief summary provided to identify what health issue this study addresses. is actively seeking new participants at 4 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05932680

Is NCT05932680 still recruiting?

Yes, NCT05932680 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05932680 recruiting?

This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05932680?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05932680 status last updated?

The official ClinicalTrials.gov record for NCT05932680 was last updated Oct 1, 2025 (October 1, 2025). HelloStudys verifies this status automatically.

Browse More I cannot determine a primary medical condition from this data. The study title mentions "Teclistamab" (a drug) and the listed condition is "OTHER:Off Drug Surveillance" which refers to monitoring rather than a medical condition. There are no keywords or meaningful brief summary provided to identify what health issue this study addresses. Trials

Ready to Apply?

Check your eligibility for this clinical trial